Abstract:Objective To study Twist and RACK-1 expressions in cervical carcinoma, and analyze the clinical significance. Methods This study enrolled the cervical carcinoma tissues (cervical carcinoma group) and para-cancerous tissues (para-carcinoma group) of 70 patients with cervical carcinoma and the normal cervical tissues (control group) of 20 patients with benign cervical tumor from May 2006 to June 2010 in the Affiliated Hospital of Southwest Medical University. Twist and RACK-1 expressions in the three groups were detected with immunohistochemical SP method. Their correlations with clinicopathological parameters of cervical carcinoma were analyzed. Results The positive expression rates of Twist in the control group, the para-carcinoma group and the cervical carcinoma group were 5.0% (1/20), 22.9% (16/70) and 95.7% (67/70) respectively, with significant differences among them (P < 0.05). The positive expression rates of RACK-1 in the control, para-carcinoma and cervical carcinoma groups were 10.0% (2/20), 61.0% (43/70) and 90.0% (63/70) respectively, with significant differences among them (P < 0.05). The expression of Twist was correlated with TNM stage, degree of tumor differentiation and lymph node metastasis (P < 0.05). The expression of RACK-1 was correlated with TNM stage, degree of tumor differentiation, depth of invasion and lymph node metastasis (P < 0.05). There was a positive correlation between Twist and RACK-1 (P < 0.05). The 5-year overall survival rates for the patients with high Twist expression (+++) and low expression (+, ++) were 51.2% and 29.2% [HR = 11.637 (95% CI: 4.351, 38.213), P = 0.002].The 5-year overall survival rates of the patients with high RACK-1 expression (+++) and low expression (+, ++) were 41.3%and 35.3% [HR = 10.143 (95% CI: 4.285, 33.275), P = 0.006]. Conclusions The up-regulated expressions of Twist and RACK-1 are closely related to the increased malignancy and invasion of cervical carcinomas. The expressions of Twist and RACK-1 might be used as indicators for prediction of the prognosis of patients with cervical carcinomas.